Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
ILA 497.5
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Matricelf Ltd, a biotechnology company, develops a platform for autologous matrix and cells implants for various medical conditions. Its regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson's disease, and myocardial infarction, as well as for 3D organ printing. Matricelf Ltd was founded in 2019...
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers.
Data is available to registered users only
Buy
Sell